It inhibits the activity of tyrosinase, an enzyme involved in melanin production, helping to reduce hyperpigmentation and dark spots
10.1007/s11095-013-1007-6 Pharm
Promotes balanced inflammatory response Referenced in studies for its potential to help regulate inflammation-related signaling
Glucagon-like peptide-1 (GLP-1) receptor agonists are a family of antihyperglycemic drugs that have demonstrated potent HbA1c reduction, low risk of hypoglycemia, with associated weight reduction, and proven cardiovascular and renal benefits.24 In this review we describe this type of drugs, their cardiovascular and renal benefits, as well as their clinical potential in patients with DKD, especially with the new oral semaglutide formulation, now available on the market
Clinical Status: GHK-Cu is an endogenous copper-binding peptide studied in both animal and human research models for wound healing, skin regeneration, and anti-aging applications
Its designed to be easy on your body and to kickstart your weight-loss goals